Oklahoma Attorney General files lawsuit against CVS Caremark

The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
Oklahoma Attorney General Gentner Drummond filed a lawsuit against CVS Caremark, alleging multiple pharmacy benefit ...
Leerink Partners maintained a Market Perform rating on CVS Health (NYSE:CVS) shares while increasing the price target from ...
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
For many living in America, healthcare is both complicated and expensive. But Mark Cuban thinks there's another way. The ...
Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...